B02 Solution/ Drops
NDC Package 63479-0202-1
Package Information
B02 (aceticum acidum, adrenalinum, american ginseng, arnica montana, balsamum peruvianum, bos taurus pituitarum posterium, cherry plum flower, chininum arsenicosum, cinchona officinalis, clematis vitalba flower, damiana, european hornbeam flower, european olive flower, glycyrrhiza glabra, impatiens glandulifera flower, kali phosphoricum, lycopodium clavatum, magnesia phosphorica, phosphoricum acidum, phosphorus, pyrenees star of bethlehem, rockrose flower, selenium metallicum, thyroidinum) solution/ dropses is for temporary relief of minor: tiredness* sadness* restlessness*exhaustion* sleepiness**Claims based on traditional homeopathic practice, not accepted medical evidence. This formulation utilizes a solution/ drops delivery system. Marketed by Apex Energetics Inc., this product is identified by NDC 63479-0202.
Identification & Billing
Clinical Specifications
- ACETIC ACID 30 [hp_X]/mL
- AMERICAN GINSENG 2 [hp_X]/mL
- ARNICA MONTANA 12 [hp_X]/mL
- BALSAM PERU 9 [hp_X]/mL
- BOS TAURUS PITUITARY GLAND, POSTERIOR 15 [hp_X]/mL
- CARPINUS BETULUS FLOWER 8 [hp_C]/mL
- CINCHONA OFFICINALIS BARK 12 [hp_X]/mL
- CLEMATIS VITALBA FLOWER 8 [hp_C]/mL
- DIBASIC POTASSIUM PHOSPHATE 12 [hp_X]/mL
- EPINEPHRINE 6 [hp_X]/mL
- GLYCYRRHIZA GLABRA 1 [hp_X]/mL
- HELIANTHEMUM NUMMULARIUM FLOWER 8 [hp_C]/mL
- IMPATIENS GLANDULIFERA FLOWER 8 [hp_C]/mL
- LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 12 [hp_X]/mL
- OLEA EUROPAEA FLOWER 8 [hp_C]/mL
- ORNITHOGALUM UMBELLATUM FLOWERING TOP 8 [hp_C]/mL
- PHOSPHORIC ACID 30 [hp_X]/mL
- PHOSPHORUS 30 [hp_X]/mL
- PRUNUS CERASIFERA FLOWER 8 [hp_C]/mL
- QUININE ARSENITE 12 [hp_X]/mL
- SELENIUM 15 [hp_X]/mL
- THYROID, UNSPECIFIED 6 [hp_X]/mL
- TURNERA DIFFUSA LEAFY TWIG 1 [hp_X]/mL
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Antimalarial - [EPC] (Established Pharmacologic Class)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 63479 - Apex Energetics Inc.
- 63479-0202 - B02
- 63479-0202-1 - 30 mL in 1 BOTTLE, GLASS
- 63479-0202 - B02
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63479-0202-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of B02 Adrenal Pep, a human over the counter drug labeled by Apex Energetics Inc.. This solution/ drops is formulated for sublingual use and contains acetic acid; american ginseng; arnica montana; balsam peru; bos taurus pituitary gland, posterior; carpinus betulus flower; cinchona officinalis bark; clematis vitalba flower; dibasic potassium phosphate; epinephrine; glycyrrhiza glabra; helianthemum nummularium flower; impatiens glandulifera flower; lycopodium clavatum spore; magnesium phosphate, dibasic trihydrate; olea europaea flower; ornithogalum umbellatum flowering top; phosphoric acid; phosphorus; prunus cerasifera flower; quinine arsenite; selenium; thyroid, unspecified; turnera diffusa leafy twig as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Apex Energetics Inc. on December 15, 1994. The current certification is valid through December 31, 2026.
How is this Apex Energetics Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63479020201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.